Jacob Teitelbaum MD
Kailua, Hawaii, 96740, United States
NCT Number: NCT04381793
The study will explore if Recovery Factors improve symptoms in fibromyalgia and chronic fatigue syndrome
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kailua, Hawaii, 96740, United States
Subjects will receive four tablets twice a day (three times a day for five day loading dose), taking the treatment for 5 - 6 weeks. Subjects will receive four tablets twice a day (three times a day for five day loading dose), taking the treatment for 5 - 6 weeks. The treatment is a unique nutritional peptide mix derived from porcine serum
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pregnant Clotting disorders
-
Porcine serum amino acid/peptide
Time frame: 6 weeks
Composite VAS (1-10) for Fatigue, Pain, Cognition, Sleep and overall well-being
Time frame: 10 weeks
Total IgG and IgG 1-4 subsets
Time frame: 6 weeks
Fibromyalgia severity scale
Practitioners Alliance Network
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03075254
Chronic Disease, Chronic Fatigue Syndrome
Gainesville, Florida, United States
View Trial DetailsNCT06006715
Bodily Distress Syndrome, Chronic Disease
View Trial DetailsNCT05811663
Bodily Distress Syndrome, Chronic Disease
Aarhus N, Denmark
View Trial DetailsNCT05631860
Bodily Distress Syndrome, Chronic Disease
View Trial Details